Lamin A/C gene mutations in familial cardiomyopathy with advanced atrioventricular block and arrhythmia

Tohoku Journal of Experimental Medicine

Volumn 218, Issue 4, 2009, Pages 309-316

  Saga, Akiko ^a   Karibe, Akihiko ^a   Otomo, Jun ^b   Iwabuchi, Kaoru ^c   Takahashi, Toshiaki ^d   Kanno, Hiroyuki ^e   Kikuchi, Junichi ^f   Keitoku, Mitsumasa ^b   Shinozaki, Tsuyoshi ^g   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU ROSAI HOSPITAL   (Japan)

^c Osaki City Hospital   (Japan)

^d Hiraka General Hospital   (Japan)

^e Katta General Hospital   (Japan)

^f Towada Municipal Central Hospital   (Japan)

^g SENDAI CITY MEDICAL CENTER   (Japan)

Author keywords

Atrioventricular block; Cardiomyopathy; Molecular genetics; Sudden death; Ventricular tachycardia

Indexed keywords

LAMIN A; LAMIN C; MEMBRANE PROTEIN;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHY; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; HEART ARRHYTHMIA; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PATHOGENESIS; PROGNOSIS; RISK ASSESSMENT; SEQUENCE ANALYSIS; SUDDEN DEATH; CELL NUCLEUS MEMBRANE; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; ONSET AGE;

ADULT; AGE OF ONSET; AGED; ARRHYTHMIAS, CARDIAC; ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHIES; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LAMIN TYPE A; MALE; MIDDLE AGED; MUTATION; NUCLEAR ENVELOPE;

EID: 70349773848     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.218.309     Document Type: Article

References (31)

1. Arbustini, E., Pilotto, A., Repetto, A., Grasso, M., Negri, A., Diegoli, M., Campana, C., Scelsi, L., Baldini, E., Gavazzi, A. & Tavazzi, L. (2002) Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J. Am. Coll. Cardiol., 39, 981-990.
2. Benson, D.W. (2004) Genetics of atrioventricular conduction disease in humans. Anat Rec A Discov Mol. Cell Evol. Biol., 280, 934-939.
3. Brodsky, G.L., Muntoni, F., Miocic, S., Sinagra, G., Sewry, C. & Mestroni, L. (2000) Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation, 101, 473-476. (Pubitemid 30080859)
4. Broers, J.L., Machiels, B.M., Kuijpers, H.J., Smedts, F., van den Kieboom, R., Raymond, Y. & Ramaekers, F.C. (1997) A- and B-type lamins are differentially expressed in normal human tissues. Histochem. Cell Biol., 107, 505-517.
5. Broers, J.L., Ramaekers, F.C., Bonne, C., Yaou, R.B. & Hutchison, C.J. (2006) Nuclear lamins: laminopathies and their role in premature ageing. Physiol. Rev., 86, 967-1008.
6. Brunner, M., Olschewski, M., Geibel, A., Bode, C. & Zehender, M. (2004) Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur. Heart J., 25, 88-95.
7. Burke, B. & Stewart, C.L. (2002) Life at the edge: the nuclear envelope and human disease. Nat. Rev. Mol. Cell Biol., 3, 575-585.
8. Eriksson, M., Brown, W.T., Gordon, L.B., Glynn, M.W., Singer J., Scott, L., Erdos, M.R., Robbins, C.M., Moses, T.Y., Berglund, P., Dutra, A., Pak, E., Durkin, S., Csoka, A.B., Boehnke, M., Glover, T.W. & Collins, F.S. (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature, 423, 293-298. (Pubitemid 40852699)
9. Fatkin, D., MacRae, C., Sasaki, T., Wolff, M.R., Porcu, M., Frenneaux, M., Atherton, J., Vidaillet, H.J. Jr., Spudich, S., De Girolami, U., Seidman, J.C., Seidman, C., Muntoni, F., Muehle, C., Johnson, W. & McDonough, B. (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N. Engl. J. Med., 341, 1715-1724.
10. Hasegawa, A., Sekiguchi, M., Hasumi, M., Take, M., Hosoda, S., Nishikawa, T. & Hiroe, M. (1990) High incidence of significant pathology in endomyocardial biopsy and familial occurrence in cases with arrhythmia and/or conduction disturbance. Heart Vessels, Supp. 5, 28-30.
11. Hennekam, R.C. (2006) Hutchinson-Gilford progeria syndrome: review of the phenotype. Am. J. Med. Genet. A, 140, 2603-2624.
12. Jakobs, P.M., Hanson, E.L., Crispell, K.A., Toy, W., Keegan, H., Schilling, K., Icenogle, T.B., Litt, M. & Hershberger, R.E. (2001) Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease. J. Card. Fail., 7, 249-256.
13. Kass, S., MacRae, C., Graber, H.L., Sparks, E.A., McNamara, D., Boudoulas, H., Basson, C.T., Baker, P.B. 3rd, Cody, R.J., Fishman, M.C., Cox, N., Kong, A., Wooley, C.E., Seidman, J.G. & Seidman, C.E. (1994) A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat. Genet., 7, 546-551.
14. Lin, F. & Worman, H.J. (1993) Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J. Biol. Chem., 268, 16321-16326.
15. Maron, B.J., Towbin, J.A., Thiene, C., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A.J., Seidman, C.E. & Young, J.B. (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation, 113, 1807-1816.
16. Mestroni, L., Maisch, B., McKenna, W.J., Schwartz, K., Charron, P., Rocco, C., Tesson, F., Richter, A., Wilke, A. & Komajda, M. (1999) Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur. Heart J., 20, 93-102.
17. Meune, C., Van Berlo, J.H., Anselme, F., Bonne, C., Pinto, Y.M. & Duboc, D. (2006) Primary prevention of sudden death in patients with lamin A/C gene mutations. N. Engl. J. Med., 354, 209-210.
18. Olson, T.M., Michels, V.V., Ballew, J.D., Reyna, S.P., Karst, M.L., Herron, K.J., Horton, S.C., Rodeheffer, R.J. & Anderson, J.L. (2005) Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA, 293, 447-454.
19. Otomo, J., Kure, S., Shiba, T., Karibe, A., Shinozaki, T., Yagi, T., Naganuma, H., Tezuka, F., Miura, M., Ito, M., Watanabe, J., Matsubara, Y. & Shirato, K. (2005) Electrophysiological and histopathological characteristics of progressive atrioventricular block accompanied by familial dilated cardiomyopathy caused by a novel mutation of lamin A/C gene. J. Cardiovasc. Electrophysiol., 16, 137-145.
20. Rober, R.A., Weber, K. & Osborn, M. (1989) Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development, 105, 365-378. (Pubitemid 19053283)
21. Schoeller, R., Andresen, D., Buttner, P., Oezcelik, K., Vey, G. & Schroder, R. (1993) First- or second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomyopathy. Am. J. Cardiol., 71, 720-726.
22. Schott, J.J., Alshinawi, C., Kyndt, F., Probst, V., Hoorntje, T.M., Hulsbeek, M., Wilde, A.A., Escande, D., Mannens, M.M. & Le Marec, H. (1999) Cardiac conduction defects associate with mutations in SCN5A. Nat. Genet., 23, 20-21.
23. Sekiguch,i M., Hasegawa, A., Hiroe, M., Morimoto, S. & Nishikawa, T. (2008) Inclusion of electric disturbance type cardiomyopathy in the classification of cardiomyopathy: a current review. J. Cardiol., 51, 81-88.
24. Shimizu, M., Ino, H., Yasuda, T., Fujino, N., Uchiyama, K., Mabuchi, T., Konno, T., Kaneda, T., Fujita, T., Masuta, E., Katoh, M., Funada, A. & Mabuchi, H. (2005) Gene mutations in adult Japanese patients with dilated cardiomyopathy. Circ. J., 69, 150-153.
25. Stuurman, N., Heins, S. & Aebi, U. (1998) Nuclear lamins: their structure, assembly, and interactions. J. Struct. Biol., 122, 42-66.
26. Taylor, M.R., Fain, P.R., Sinagra, C., Robinson, M.L., Robertson, A.D., Carniel, E., Di Lenarda, A., Bohlmeyer, T.J., Ferguson, D.A., Brodsky, C.L., Boucek, M.M., Lascor, J., Moss, A.C., Li, W.L., Steuer, G.L., Muntoni, F., Bristow, R. & Mestroni, L. (2003) Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J. Am. Coll. Cardiol., 41, 771-780.
27. van Berlo, J.H., de Voogt, W.G., van der Kooi, A.J., van Tintelen, J.P., Bonne, C., Yaou, R.B., Duboc, D., Rossenbacker, T., Heidbuchel, H., de Visser, M., Crijns, H.J. & Pinto, Y.M. (2005) Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J. Mol. Med., 83, 79-83.
28. Waller, B.F., Gering, L.E., Branyas, N.A. & Slack, J.D. (1993) Anatomy, histology, and pathology of the cardiac conduction system - Part V. Clin. Cardiol., 16, 565-569.
29. Wolf, C.M., Wang, L., Alcalai, R., Pizard, A., Burgon, P.G., Ahmad, F., Sherwood, M., Branco, D.M., Wakimoto, H., Fishman, G.I., See, V., Stewart, C.L., Conner, D.A., Berul, C.I., Seidman, C.E. & Seidman, J.G. (2008) Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease. Mol. Cell Cardiol., 44, 293-303.
30. World Health Organization / International Society and Federation of Cardiology Task Force. (1996) Report of the 1995 World Health Organization / International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation, 93, 841-842.
31. Xiao, H.B., Roy, C., Fujimoto, S. & Gibsonm, D.G.. (1996) Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int. J. Cardiol., 53, 163-170.